Abbvie Endocrine Company Profile
What is the competitive landscape for ABBVIE ENDOCRINE
ABBVIE ENDOCRINE has seven approved drugs.
There are two US patents protecting ABBVIE ENDOCRINE drugs.
Summary for Abbvie Endocrine
| US Patents: | 2 |
| Tradenames: | 4 |
| Ingredients: | 2 |
| NDAs: | 7 |
Drugs and US Patents for Abbvie Endocrine
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie Endocrine Inc | LUPRON | leuprolide acetate | SOLUTION;SUBCUTANEOUS | 019010-001 | Apr 9, 1985 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Abbvie Endocrine Inc | LUPRON DEPOT-PED KIT | leuprolide acetate | POWDER;INTRAMUSCULAR | 020263-003 | Apr 16, 1993 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Abbvie Endocrine Inc | LUPRON DEPOT-PED KIT | leuprolide acetate | POWDER;INTRAMUSCULAR | 020263-002 | Apr 16, 1993 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020517-003 | Jun 17, 2011 | RX | Yes | Yes | 9,617,303 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020517-003 | Jun 17, 2011 | RX | Yes | Yes | 8,921,326 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Abbvie Endocrine | LUPANETA PACK | leuprolide acetate; norethindrone acetate | INJECTABLE, TABLET;INTRAMUSCULAR, ORAL | 203696-001 | Dec 14, 2012 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Abbvie Endocrine Inc | LUPRON DEPOT-PED KIT | leuprolide acetate | POWDER;INTRAMUSCULAR | 020263-008 | Aug 15, 2011 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Abbvie Endocrine
International Patents for Abbvie Endocrine Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Norway | 347209 | ⤷ Start Trial |
| Norway | 20092662 | ⤷ Start Trial |
| European Patent Office | 2094246 | ⤷ Start Trial |
| Dominican Republic | P2009000144 | ⤷ Start Trial |
| Tunisia | 2009000197 | ⤷ Start Trial |
| Ecuador | SP099439 | ⤷ Start Trial |
| South Korea | 20090094272 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
